Previous Close | 2.7220 |
Open | 2.7000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's Range | 2.7000 - 2.7400 |
52 Week Range | 1.7000 - 3.1400 |
Volume | |
Avg. Volume | 1,411 |
Market Cap | N/A |
Beta (5Y Monthly) | 2.09 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.10178 EPS, expectations were $-0.1. Arbutus Biopharma Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Arbutus Biopharma ( NASDAQ:ABUS ) First Quarter 2024 Results Key Financial Results Revenue: US$1.53m (down 77% from 1Q...
Insights into Arbutus Biopharma Corp's Q1 performance, including financial updates and progress in clinical trials.